The Efficacy of Oral Dissolution Therapy (ODT), Extracorporeal Shock Wave Lithotripsy (ESWL), and Combined ESWL and ODT as Non-Invasive Modalities for Treating Small and Medium-Sized Radiolucent Renal Stones

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

December 20, 2024

Study Completion Date

December 20, 2024

Conditions
Oral Dissolution TherapyExtracorporeal Shock Wave LithotripsyNoninvasiveSmallMediumRadiolucent Renal Stones
Interventions
DRUG

Oral dissolution therapy

Patients received guidance for oral potassium-sodium-hydrogen-citrate (6:6:3:5) at a dosage of twenty milliequivalents three times every day, along with a daily fluid intake of two to three liters and a food plan to restrict protein and sodium consumption for a maximum of three months.

PROCEDURE

Extracorporeal shock wave lithotripsy

Patients received extracorporeal shock wave lithotripsy utilizing a Dornier lithotripter equipped with an integrated ultrasound for stone localization. If the patient required additional sessions, up to a maximum of four sessions, at a rate of 60-90 shocks per minute, the period between sessions was three weeks.

PROCEDURE

Oral dissolution therapy + extracorporeal shock wave lithotripsy

Patients received a combination of oral dissolution therapy and extracorporeal shock wave lithotripsy.

Trial Locations (1)

12613

Cairo University, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT06814834 - The Efficacy of Oral Dissolution Therapy (ODT), Extracorporeal Shock Wave Lithotripsy (ESWL), and Combined ESWL and ODT as Non-Invasive Modalities for Treating Small and Medium-Sized Radiolucent Renal Stones | Biotech Hunter | Biotech Hunter